BD and Hamilton Robotics Launch Automation-Ready Reagents to Transform Genomic Sequencing Workflows

  Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing&nb...

October 15, 2024 | Tuesday | News
Sandoz Launches First FDA-Approved Generic Paclitaxel for Metastatic Breast Cancer

First FDA-approved abbreviated new drug application (ANDA) to reference medicine Single-dose 100 mg vial for intravenous use, approved for metastatic ...

October 14, 2024 | Monday | News
Aileron Therapeutics Showcases Promising LTI-03 Results for Idiopathic Pulmonary Fibrosis at ICLAF

Aileron Therapeutics,  a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs i...

October 14, 2024 | Monday | News
RIVANNA® Launches First Multi-Site Study Using Accuro® XV Musculoskeletal Imaging System

RIVANNA®, developers of imaging-based medical solutions, has announced the launch of the first multi-site study employing the Accuro® XV musculos...

October 11, 2024 | Friday | News
New MammoScreen® AI Enhances Breast Cancer Screening with Comprehensive Workflow Features

New MammoScreen® AI delivers a comprehensive suite of features including breast density and pre-reporting, creating the ultimate ...

October 11, 2024 | Friday | News
Dräger India Launches BabyRoo® TN 300, Transforming Newborn Care with Advanced Thermoregulation and Family-Centered Technologies

Dräger India is proud to announce the launch of the BabyRoo® TN 300 open warmer, with state-of-the-art thermoregulation capabilities as well as ad...

October 10, 2024 | Thursday | News
HBC Immunology Achieves Breakthrough in Prostate Cancer Treatment with Novel Peptide FT-002a

HBC Immunology (HBCI) is pleased to announce the successful completion of its prostate cancer treatment xenograft studies with its lead peptide FT-002a i...

October 09, 2024 | Wednesday | News
PROCEPT BioRobotics Launches FDA-Approved Trial Comparing Aquablation to Prostatectomy for Cancer Treatment

A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate C...

October 08, 2024 | Tuesday | News
Global TB Summit 2024: QIAGEN’s QuantiFERON®-TB Gold Plus Blood Test at the Forefront of Latent TB Detection and Global Disease Control

QIAGEN’s leading tuberculosis blood test QuantiFERON®-TB Gold Plus remains crucial for detection of latent tuberculosis infection, aiding in ...

October 08, 2024 | Tuesday | News
Oncocyte's GraftAssure™ Assay Adopted by Top U.S. and German Transplant Hospitals, Progresses Toward FDA Submission

GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volume Company clears first stage...

October 03, 2024 | Thursday | News
NextGen Healthcare Expands AI-Driven Ambient Listening to Ophthalmologists and Optometrists

  NextGen Healthcare announced that its AI-driven ambient listening solution NextGen® Ambient Assist is now available to ophthalmologists and opt...

October 02, 2024 | Wednesday | News
Olympus Launches VISERA S1: A Major Advancement in ENT Imaging with Integrated Stroboscopy

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced th...

October 01, 2024 | Tuesday | News
Transforming Vision: Jacqueline Henderson on Johnson & Johnson's Groundbreaking IOL Innovations

As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development...

October 01, 2024 | Tuesday | Interview
SIFI Secures European Patent for Innovative Polihexanide Formulation in Germany Eye Infection Treatment

The company's intellectual property ("IP") covers the formulation and method of use of polihexanide in the treatment of acanthamoeba keratitis and fung...

September 30, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close